Sequence Similarity Clusters for the Entities in PDB 1I8K

Entity #1 | Chains: A
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN protein, length: 107 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 35793
95 % 1 2 30530 Flexibility: Low
Max RMSD: 0.8, Avg RMSD: 0.8
PDBFlex
90 % 1 2 29280
70 % 1 2 26307
50 % 45 317 23
40 % 51 361 27
30 % 687 7175 1
Entity #2 | Chains: B
EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN protein, length: 124 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 2 35792
95 % 1 2 30529 Flexibility: No
Max RMSD: 0.3, Avg RMSD: 0.3
PDBFlex
90 % 1 2 29279
70 % 86 409 9
50 % 106 609 6
40 % 564 5756 1
30 % 688 7175 1
Entity #3 | Chains: C
EPIDERMAL GROWTH FACTOR RECEPTOR, EGFRVIII PEPTIDE ANTIGEN protein, length: 12 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
3 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
4 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
5 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
6 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
7 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
8 5L6Q 1 A, B H5AL 9606
9 5C2B 2 L 3B4 light chain 9606
10 3T0W 1 A, B immunoglobulin variable lambda domain 9606
11 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
12 3T0V 1 A immunoglobulin variable lambda domain 9606
13 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
14 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
15 1SQ2 2 N novel antigen receptor 7801
16 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
17 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
18 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
19 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
20 3CDC 1 A, B Light Chain Amyloidogenic 9606
21 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
22 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
23 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
24 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
25 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
26 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
27 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
28 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
29 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
30 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
31 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
32 5IR3 1 A Ig lambda chain V-VI region AR 9606
33 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
34 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
35 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
36 5L8L 2 B New antigen receptor variable domain 168098
37 4AIZ 1 A, C, D V2-17 PROTEIN 9606
38 4AIZ 2 B V2-17 PROTEIN 9606
39 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
40 4L1H 1 A Ig kappa chain V-I region Rei 9606
41 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
42 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
43 3BD3 1 A, B catalytic antibody 10090
44 2OTU 1 A, C, E, G Fv light chain variable domain 10090
45 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
46 5L8J 2 B New antigen receptor variable domain 168098
47 1T6V 2 N, O novel antigen receptor 7801
48 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
49 4N1C 1 A, B immunoglobulin variable light chain domain 9606
50 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
51 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
52 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
53 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
54 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
55 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
56 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
57 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
58 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
59 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
60 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
61 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
62 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
63 5L8K 2 B New antigen receptor variable domain 168098
64 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
65 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
66 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
67 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
68 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
69 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
70 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
71 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
72 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
73 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
74 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
75 1KIQ 1 A MONOCLONAL ANTIBODY D1.3 10090
76 2IMN 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
77 3B5G 1 A, B AMYLOID LAMBDA 6 LIGHT CHAIN VARIABLE REGION PIP residues 1-111 9606
78 3DUR 1 A, C antibody Fv fragment SAG173-04 variable region fragment (Fv) 10090
79 5T93 1 A, B, C, D ALT-05 immunoglobulin light chain variable domain from light chain amyloidosis patient last residue was not visible on electron density 9606
80 1LVE 1 A LEN, A VARIABLE DOMAIN FROM KAPPA-4 TYPE 9606
81 2IMM 1 A IGA-KAPPA MCPC603 FV (LIGHT CHAIN) 10090
82 5C9K 1 A, B, C, D, E, F, G, H Amyloid lambda 6 light chain variable region PIP 9606
83 1FGV 1 L H52 FV (LIGHT CHAIN) 9606
84 4LCI 1 L anti canine CD28 antibody, 1C6, light chain 10090
85 1A7N 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
86 1CD0 1 A, B PROTEIN (JTO, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) IMMUNOGLOBULIN VARIABLE DOMAIN 9606
87 4LRN 2 L GEP 1 light chain 9606
88 1EK3 1 A, B KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN VL, REC 9606
89 2YC1 2 B, E SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN 9606
90 1G7H 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
91 1A7O 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
92 1KIR 1 A MONOCLONAL ANTIBODY D1.3 10090
93 2DQE 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
94 1DVF 1 A FV D1.3 IGG1, KAPPA 10090
95 1DVF 3 C FV E5.2 IGG1, KAPPA 10090
96 1G7M 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
97 1OAU 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
98 1B0W 1 A, B, C BENCE-JONES KAPPA I PROTEIN BRE VARIABLE DOMAIN OF LIGHT CHAIN 9606
99 1A6W 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
100 1A7R 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
101 1WZ1 1 L Ig light chain 10090
102 3UPA 1 A, B kappa light chain variable domain 9606
103 3LVE 1 A LEN KAPPA-IV LIGHT CHAIN DIMER 9606
104 1A7P 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
105 4K3G 1 A, B immunoglobulin lambda variable domain L5(L89S) 9606
106 1XIW 3 C, G immunoglobulin light chain variable region 10090
107 5NGV 3 L anti-human ActRIIB mAb BYM338 light-chain VL 9606
108 1A7Q 1 L IGG1-KAPPA D1.3 FV (LIGHT CHAIN) FV FRAGMENT 10090
109 1DSF 1 L ANTICANCER ANTIBODY B1 FV 10090
110 3DUU 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
111 3BJ9 1 1 Immunoglobulin iota chain, Immunoglobulin lambda-like polypeptide 1 Fusion protein consists of Ig domain of VPREB protein and J-fragment of Ig lambda-5 9606
112 1H5B 1 A MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
113 1H5B 2 B, D MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
114 1H5B 3 C MURINE T CELL RECEPTOR (TCR) VALPHA DOMAIN C-TERMINAL HEXA-HISTIDINE TAG V-ALPHA DOMAIN VA85.33 (AV11S5-AJ17) 10090
115 3LRG 1 A, B anti-huntingtin VL domain anti-huntingtin VL domain 9606
116 1KIP 1 A MONOCLONAL ANTIBODY D1.3 10090
117 5LVE 1 A BENCE-JONES PROTEIN LEN G KAPPA CHAIN V-IV, VARIABLE DOMAIN, LIGHT CHAIN 9606
118 2EIZ 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
119 1PW3 1 A, B immunoglobulin lambda chain variable region 9606
120 5JPJ 1 A, B 6aJL2 protein 9606
121 2UZI 2 L ANTI-RAS FV LIGHT CHAIN 9606
122 2I27 1 N, O New Antigen Receptor Ancestral variable domain 7801
123 3T0X 1 A, B Immunoglobulin variable lambda domain M8VLA4(S55P) 9606
124 1UA6 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
125 1IC7 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
126 1CFV 1 L MONOCLONAL ANTIBODY FV4155 FV FRAGMENT 10090
127 1QP1 1 A, B, C BENCE-JONES KAPPA I ANTIBODY BRE (LIGHT CHAIN) IMMUNOGLOBULIN FRAGMENT, VARIABLE DOMAIN 9606
128 3U7A 1 A Amyloidogenic immunoglobulin light chain protein AL-09 Y32F Y96F, variable domain 9606
129 4UU9 2 B, L MEDI7814 VARIABLE DOMAIN LIGHT CHAIN 9606
130 3MOQ 1 A, B, C, D New antigen receptor variable domain,P3(40) peptide from Amyloid beta A4 protein,New antigen receptor variable domain CHIMERA OF NEW ANTIGEN RECEPTOR VARIABLE DOMAIN (RESIDUES 1-87 AND 102-113 FROM UNP Q6X1E6) INSERTED WITH AMYLOID BETA 18-41 (RESIDUES 689-712 FROM UNP P05067) 168098
131 1G7L 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
132 1BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
133 1IVL 1 A, B IGG-KAPPA M29B FV (LIGHT CHAIN) 10090
134 1A6U 1 L B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
135 2DQI 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
136 1BRE 1 A, B, C, D, E, F BENCE-JONES KAPPA I PROTEIN BRE 9606
137 3CX5 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
138 5B8C 1 A, D, G, J Pembrolizumab light chain variable region (PemVL) 9606
139 3DV6 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
140 1VES 1 A, B New Antigen Receptor variable domain 168098
141 2EKS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
142 3BD5 1 A, B catalytic antibody 10090
143 4XVJ 3 L antibody light chain variable domain 9606
144 1AC6 1 A, B T-CELL RECEPTOR ALPHA VARIABLE DOMAIN 10090
145 1JV5 1 A Ig kappa chain precursor V region anti-blood group A Fv 9606
146 1FVC 1 A, C IGG1-KAPPA 4D5 FV (LIGHT CHAIN) 9606
147 4Z0X 1 A Antibody HC26AM light chain variable domain 9606
148 1IC5 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
149 2CD0 1 A, B PROTEIN (BENCE-JONES PROTEIN WIL, A VARIABLE DOMAIN FROM LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN) VARIABLE DOMAIN 9606
150 4LAS 2 L Single light chain Variable fragment Light Chain 10090
151 2A9M 1 L, M fluorescein-scfv light chain 9606
152 2YWZ 1 A new antigen receptor variable domain 168098
153 1A6V 1 L, M, N B1-8 FV (LIGHT CHAIN) FV FRAGMENT 10090
154 3DUS 1 A, C antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
155 5NH3 3 L, M anti-human ActRIIB mAb BYM338 Fv light-chain 9606
156 2COQ 1 A new antigen receptor variable domain 168098
157 5GRV 2 K homo-specific diabody light chain 9606
158 2GSG 1 A, C monoclonal antibody light chain variable domain 10090
159 2W0L 1 A, B, C, D V1-22 PROTEIN 9606
160 5TBD 2 B, F, G, K Fv fragment (mAb4D1) heavy chain 10090
161 5DHV 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
162 4LVE 1 A, B LEN KAPPA-IV LIGHT CHAIN DIMER 9606
163 43C9 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
164 1NMB 2 L FAB NC10 RESOLUTION OF 2.5 ANGSTROMS 10090
165 1I8I 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
166 1OAR 2 L, M, N, O IMMUNOGLOBULING E FV, RESIDUES 1-110 10090
167 1D9K 1 A, E T-CELL RECEPTOR D10 (ALPHA CHAIN) 10090
168 3DV4 1 A antibody Fv fragment SAG506-01 variable region fragment (Fv) 10090
169 1I3G 1 L ANTIBODY FV FRAGMENT VL DOMAIN 10090
170 1DL7 1 L PROTEIN (ANTIBODY M3C65 (LIGHT CHAIN)) COMBINED LIGHT AND HEAVY CHAIN VIA (G4S)3 LINKER FV (SINGLE CHAIN) 10090
171 1OCW 2 L IMMUNOGLOBULIN E FV REGION, RESIDUES 1-120 10090
172 1IGM 1 L IGM-KAPPA POT FV (LIGHT CHAIN) 9606
173 5GS1 1 A, M, O, Q light chain 9606
174 2DQG 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
175 2PXY 1 A T cell receptor alpha chain 10090
176 3BDX 1 A, B, C Amyloid lambda 6 light chain variable region PIP (fragment) Residues 1-111 9606
177 43CA 1 A, C, E, G PROTEIN (IMMUNOGLOBULIN (LIGHT CHAIN)) FV 10090
178 2DQH 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
179 2Q1E 1 A, B, C, D Amyloidogenic immunoglobulin light chain protein AL-09 9606
180 3EHB 4 D FV fragment Chain L 10090
181 3HB3 4 D ANTIBODY FV FRAGMENT 10090
182 4FFY 1 L DENV1-E111 single chain variable fragment (light chain) 10090
183 4N1E 1 A, B, C, D, E, F, G, H immunoglobulin variable light chain domain 9606
184 5LBS 3 L, M BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 SCFV fragment, light chain 9606
185 1AP2 1 A, C MONOCLONAL ANTIBODY C219 LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER FV 10090
186 1IC4 1 L LYSOZYME BINDING IG KAPPA CHAIN 10090
187 3CDY 1 A, B IMMUNOGLOBULIN LIGHT CHAIN 9606
188 4RAV 1 B, D Single-chain Fv, VL 9606
189 5XJ4 3 L durvalumab-VL 9606
190 5LWY 3 L V REGION LIGHT CHAIN 10090
191 1KB9 11 K LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
192 4X4X 2 B, D Human Variable Light Chain of Herceptin 9606
193 2Z8V 2 C, D New antigen receptor variable domain 168098
194 2W0K 1 A, B V1-22 PROTEIN 9606
195 2BFV 1 L FV4155 MONOCLONAL ANTIBODY FV FRAGMENT 10090
196 2IBZ 11 Y Variable Light chain of antibody fragment 10090
197 4K3H 1 A, B, C, D, E, F, G, H Immunoglobulin lambda variable domain L5(L89S) 9606
198 2Z8W 2 C, D New antigen receptor variable domain 168098
199 2OI9 2 B T cell receptor alpha chain 10090
200 4HGM 1 A Shark V-NAR 7797
201 3BD4 1 A, B catalytic antibody 10090
202 1WT5 2 C, D ANTI EGFR ANTIBODY FV REGION VL fragment 9606
203 1JHL 1 L IGG1-KAPPA D11.15 FV (LIGHT CHAIN) 10090
204 4LLV 2 B, D, F, L 4E10 Fv light chain 9606
205 4LAR 2 L Single light chain variable fragment Light Chain 10090
206 5CBA 2 B, D 3b4 light chain 9606
207 1A14 3 L NC10 FV (LIGHT CHAIN) VL DOMAIN OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIVE-RESIDUE POLYPEPTIDE LINKER 10090
208 1C08 1 A ANTI-HEN EGG WHITE LYSOZYME ANTIBODY (HYHEL-10) VL FRAGMENT 10090
209 2OTW 1 A, C Fv light chain avriable domain VL 10090
210 2YSS 1 A ANTI-LYSOZYME ANTIBODY FV REGION VL FRAGMENT 9606
211 2YBR 2 B, E, H SINGLE CHAIN ANTIBODY FRAGMENT 9004G LIGHT CHAIN, RESIDUES 118-263 9606
212 2I26 1 N, O, P New Antigen Receptor Ancestral variable domain 7801
213 2BJM 2 L IGE SPE7 LIGHT CHAIN LIGHT CHAIN, RESIDUES 1-110 10090
214 1P4B 1 L Antibody Variable light chain 10090
215 4Y5V 2 B, E, H Diabody 305 VL domain 9606
216 1I9E 1 A CYTOTOXIC TCELL VALPHA DOMAIN N-TERMINAL DOMAIN OF ALPHA CHAIN 10090
217 1DQL 1 L IGM MEZ IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN FRAGMENT 9606
218 2Z35 1 A T-cell receptor alpha-chain 10090
219 4X4Y 2 B, D Human Variable Light Chain of Herceptin 9606
220 1VER 1 A New Antigen Receptor variable domain 168098
221 4YQX 2 L, O JES6-1 VL domain 10116
222 1FO0 4 A PROTEIN (BM3.3 T CELL RECEPTOR ALPHA-CHAIN) FV FRAGMENT, VARIABLE DOMAIN 10090
223 1EZV 11 Y LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
224 3U6R 2 B, L Antibody 1:7 (Light chain) 9606
225 1U3H 1 A, E T-cell receptor alpha-chain V2.3-J39-C 10090
226 2YWY 1 A, B, C, D new antigen receptor variable domain 168098
227 1NMC 3 C, L SINGLE CHAIN ANTIBODY VH AND VL DOMAINS OF ANTI-NEURAMINIDASE ANTIBODY NC10 COVALENTLY JOINED BY A FIFTEEN RESIDUE POLYPEPTIDE LINKER 10090
228 1KB5 1 A KB5-C20 T-CELL ANTIGEN RECEPTOR 24 RESIDUE LINK BETWEEN VALPHA C-TERMINUS AND VBETA N-TERMINUS FV FRAGMENT, VARIABLE DOMAIN 10090
229 2DQF 1 A, D lysozyme binding Ig kappa chain V23-J2 region 10090
230 1B88 1 A, B T CELL RECEPTOR V-ALPHA DOMAIN V-ALPHA DOMAIN 10090
231 3CXH 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT 10090
232 2E7L 1 A, B Cytotoxic Tcell receptor UNP RESIDUES 21-132 10090
233 5YOY 2 D, E, F, M, N, O Golimumab light chain variable region 9606
234 2ICW 5 I, K T-cell receptor alpha chain V residues 21-131 10090
235 1P84 11 K Light Chain (Vl) Of Fv-Fragment 10090
236 2XTJ 2 B FAB FROM A HUMAN MONOCLONAL ANTIBODY, 1D05 LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
237 5CBE 2 B, D E10 light chain 9606
238 3WXW 3 L V region light chain 10090
239 1F6L 1 L ANTI-FERRITIN IMMUNOGLOBULIN LIGHT CHAIN VARIABLE LIGHT CHAIN 9606
240 3LRH 1 A, C, E, G, I, K, M, O anti-huntingtin VL domain anti-huntingtin VL domain 9606
241 1AR1 4 D ANTIBODY FV FRAGMENT 10090
242 1BVK 1 A, D HULYS11 FV 9606
243 5FV1 1 L, M VK DOMAIN ANTIBODY VK DOMAIN ANTIBODY, RESIDUES 1-108 9606
244 2CJU 2 L NQ16-113.8 ANTI-PHOX ANTIBODY 10090
245 1P4I 1 L ANTIBODY VARIABLE LIGHT CHAIN 10090
246 2LVE 1 A RLEN KAPPA-IV LIGHT CHAIN DIMER 9606
247 2VH5 2 L ANTI-RAS FV LIGHT CHAIN 9606
248 3LH2 3 L, M, N, O Fv 4E10 light chain 9606
249 1OAZ 3 L, N IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
250 1KJ2 4 A, D KB5-C20 T-Cell receptor alpha-chain Fv fragment , variable domain 10090
251 1OAY 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
252 4LAQ 2 L Single light chain variable fragment Light Chain 10090
253 5LXG 3 L V REGION LIGHT CHAIN 10090
254 4RZC 2 B, D, F, L Fv M6P-1 heavy chain 9986
255 3H3P 2 L, M Fv 4E10 light chain 9606
256 3NN8 2 B, E, F, H Engineered scFv, light chain 10090
257 1OAX 2 L, M, N, O IMMUNOGLOBULIN E FV REGION, RESIDUES 1-110 10090
258 4V1D 2 B SINGLE CHAIN ANTIBODY FRAGMENT LR, LIGHT CHAIN 9606
259 4V1D 5 E SINGLE CHAIN ANTIBODY FRAGMENT RU1, LIGHT CHAIN 9606
260 2Z31 1 A T-cell receptor alpha-chain 10090
261 1NMA 2 L FAB NC10 RESOLUTION OF 3.0 ANGSTROMS 10090
262 1NAM 1 A BM3.3 T Cell Receptor alpha-Chain Fv Fragment, Variable Domain 10090
263 4Y5Y 2 B, E diabody 330 VL domain 9606
264 1BVL 2 B, D HULYS11 FV 10090
265 4UNT 1 A, B, C, D, E, F, G, H IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
266 3AB0 3 C, F antibody ScFv fragment, light chain 10090
267 3LHP 2 L, M Fv 4E10 light chain 9606
268 2BX5 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O VD9 VKI LIGHT-CHAIN LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-107 9606
269 6CK9 3 E 35O22 scFv light chain portion 9606
270 2UUD 2 K, L NQ10-1.12 ANTI-PHOX ANTIBODY 10090
271 4Y5X 2 B, E, H, K diabody 310 VH domain 9606
272 4UT9 3 L, M, N, O BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C10 SCFV, LIGHT CHAIN DOMAIN 9606
273 2A9N 1 L, M fluorescein-scfv light chain 9606
274 5XQY 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 Y96K mutant of REI VL 9606
275 5GS0 2 C, E light chain (anti-TLR3) 10090
276 5GS0 5 L, Y light chain (anti-Lid) 10090
277 1KYO 11 K, V LIGHT CHAIN (VL) OF FV-FRAGMENT RESIDUES 1-107 10090
278 5GRJ 2 L avelumab L chain 9606
279 4NKD 2 B, D, F, H Engineered scFv light chain 10090
280 3WXV 3 L V region light chain 10090
281 1AR2 1 A REI VARIABLE REGION, LIGHT CHAIN 9606
282 4KV5 3 F, I, K, L light chain GC1009 scFv 9606
283 1QLE 6 L LIGHT CHAIN ANTIBODY FV FRAGMENT 10090
284 3E3Q 3 C, D, I, M, R, V, Z, d T-cell receptor alpha chain V region PHDS58 10090
285 5XP1 1 A, B, C, D, E, F, G, H Immunoglobulin kappa variable 1D-33 UNP residues 22-117 9606
286 5XJ3 2 B, E, H, K ipilimumab-VL 9606
287 4M8Q 2 B, L GEP1 Fv light chain UNP residues 21-129 9606
288 5NHR 1 B, L Bimagrumab Fv Light-Chain VL domain LIGAND BINDING domain 9606
289 5J3H 3 D mAb 83-7 Fab light chain 10090
290 5U8R 3 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
291 5XWD 3 D VL chain of 059-152 9606
292 4YBQ 2 C, E antibody Fv fragment light chain 10090
293 4PD4 11 K Ig kappa chain V-V region HP 124E1 10090
294 4R0L 3 B, L Antibody 1C6 Light chain UNP residues 20-137 10090
295 5U8Q 4 L Fv 24-60 light chain Light chain variable domain (residues 1-107) of mAb 24-60, including additional Gly at the N terminus. 10090
296 4ODX 3 B, L GEP7 Fv light chain 9606
297 3E2H 3 B T-cell receptor alpha chain V region PHDS58 10090
298 4H1L 4 G, I Ani2.3 TCR A chain 562
299 1RVF 5 L FAB 17-IA 10090
300 5JZ7 3 D, I, K, L MEDI578 scFv, light chain 9606
301 5DHY 2 B, L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
302 1QFW 3 L ANTIBODY (ANTI ALPHA SUBUNIT) (LIGHT CHAIN) FV 10090
303 1QFW 5 M ANTIBODY (ANTI BETA SUBUNIT) (LIGHT CHAIN) FV 10090
304 4OGA 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
305 4NKM 2 B, D, F, H Engineered scFv light chain 10090
306 3W11 4 D monoclonal antibody fab 83-7 fragment - light chain 10090
307 4NKO 1 A, C, E Engineered scFv light chain 10090
308 3W13 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
309 3W12 3 D monoclonal antibody fab 83-7 fragment - light chain 10090
310 5DHZ 2 L Anti-Rev Antibody Fab single-chain variable fragment, light chain 9986
311 2A0L 2 C, E 33H1 Fv fragment Fv fragment,light chain 10090
312 5WDU 3 E, P, X bnAb NIH45-46 scFv light chain 9606
313 6CDI 3 6, N, n PGT122 Light Chain 9606
314 6CDI 5 7, R, r VRC03 light chain 9606
315 6BSP 2 B U4 Light chain 10090
316 5Y0A 3 E, G, L variable region of Fab ZKA190 light chain 9606
317 5XS7 1 L Light chain of Fab 1D5 10090
318 5W3L 6 G C5 antibody variable light domain 10090
319 5W3M 2 G C5 antibody variable light domain 10090
320 5W3O 2 E C5 antibody variable light domain 10090
321 5W3E 2 G C5 antibody variable light domain 10090
322 5TR1 3 L, M Monoclonal antibody, Fab fragment, light chain 10090
323 5TQQ 2 L, M Monoclonal antibody, Fab fragment, light chain 10090
324 5H32 3 H, L, M C10 IgG light chain variable region 9606
325 5H37 4 H, L, M C10 IgG light chain variable region 9606
326 5H30 4 H, L, M IgG C10 light chain 9606
327 5KEL 4 L, T, U c2G4 variable Fab domain light chain 9606
328 5KEL 6 D, N, O c13C6 variable Fab domain light chain 9606
329 5KEM 1 C, H BDBV91 variable Fab domain light chain 9606
330 5KEM 4 E, J c13C6 variable Fab domain light chain 9606
331 5KEN 4 D, H, O c4G7 variable Fab domain light chain 9606
332 5KEN 5 I, P c13C6 variable Fab domain light chain 9606
333 3JCX 3 L Fab E light chain 10116
334 3JBA 1 L H16.U4 antibody light chain Fab variable domain 10090
335 3JAU 3 L Light chain of Fab fragment variable region of antibody D5 10090
336 5A1Z 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 180 COPIES OF FAB 2D22 MOLECULE BIND TO VIRUS SURFACE 9606
337 4UIF 4 H, J, L ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 - LIGHT CHAIN 9606
338 4UIH 3 E, G ANTIGEN-BINDING FRAGMENT OF HUMAN ANTIBODY 2D22 -LIGHT CHAIN 9606
339 4UDF 3 10, 14, 18, 1C, 1G, 1K, 1O, 1S, 1W, 20, 24, 28, 2C, 2G, 2K, 2O, 2S, 2W, 30, 34, 38, 3C, 3G, 3K, 3O, 3S, 3W, 40, 44, 48, 4C, 4G, 4K, 4O, 4S, 4W, 50, 54, 58, 5C, 5G, 5K, 5O, 5S, 5W, 60, 64, 68, 6C, 6G, 6K, 6O, 6S, 6W, 7C, 7G, 7K, 7O, 7S, 7W HUMAN MONOCLONAL ANTIBODY 9606
340 3J8Z 2 J, K, L, M H16.1A light chain variable domain Fab 10090
341 3J8V 2 J, K, L, M H16.14J light chain variable domain Fab 10090
342 3J8W 1 J, K, L, M H263.A2 light chain variable domain Fab 10090
343 3J7E 1 A, C, E, L H16.V5 Fab light chain variable domain 10090
344 3J6U 4 L Fab 5J7 light chain variable region 9606
345 2MMX 1 A V1-22 protein 9606
346 2MKW 1 A V1-22 protein 9606
347 4CKD 3 L, M, N, O SCFV13R4 ANTIBODY FV LIGHT CHAIN 10090
348 2KQM 1 A, B Ig kappa chain V-I region AU Immunoglobulin kappa light chain 9606
349 2KQN 1 A, B Ig kappa chain V-I region AU Immunoglobulin kappa light chain 9606
350 3IY1 1 A Fab B, light chain antibody B fragment 10116
351 3IY2 1 A Antibody 6, light chain fragment of antibody 6 10090
352 3IY3 1 A antibody fragment from neutralizing antibody 8 (light chain) FAb 8 10090
353 3IY4 1 A fragment of neutralizing antibody 15 (light chain) fragment of neutralizing antibody 15 10090
354 3IY5 1 A antibody fragment IGG2A (light chain) Fab 10090
355 3IY6 1 A fragment from neutralizing antibody E (light chain) FAb E 10116
356 3IY7 1 A fragment from neutralizing antibody F (light chain) FAb F 10116
357 3IY0 1 L Fab 14, light domain Fab14 10090
358 1QNZ 2 L 0.5B ANTIBODY (LIGHT CHAIN) FV 10090
359 1MAJ 1 A IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) 10090
360 1MAK 1 A IGG2A-KAPPA 26-10 FV (LIGHT CHAIN) 10090
361 1REI 1 A, B BENCE-JONES PROTEIN REI (LIGHT CHAIN) 9606